Summary by Moomoo AI
CSPC Pharma Limited (CSPC Pharma) submitted a new disclosure report on June 25, 2024, disclosing the changes in its shareholding. According to the report, CSPC Pharma repurchased 10,000,000 shares, 7,900,000 shares, and 9,350,000 shares on June 21, June 24, and June 25, 2024, respectively, at repurchase prices of HKD 6.3613, HKD 6.2648, and HKD 6.3517. The total number of repurchased shares is 27,250,000, accounting for 0.23% of the issued shares. The repurchased shares will be cancelled. This share repurchase was carried out under the repurchase authorization obtained by the company on May 28, 2024, which allows CSPC Pharma to repurchase up to 1,189,609,173 shares. After the repurchase, the total number of issued shares of CSPC Pharma remains at 11,896,091,732 shares, with no new shares issued or inventory shares resold or transferred. The company secretary, Luo Taian, confirmed the compliance of the repurchase activity.